Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Defining new criteria for selection of cell-based intestinal models using publicly available databases.

Christensen J, El-Gebali S, Natoli M, Sengstag T, Delorenzi M, Bentz S, Bouzourene H, Rumbo M, Felsani A, Siissalo S, Hirvonen J, Vila MR, Saletti P, Aguet M, Anderle P.

BMC Genomics. 2012 Jun 22;13:274. doi: 10.1186/1471-2164-13-274.

2.

Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium.

Lenaerts K, Bouwman FG, Lamers WH, Renes J, Mariman EC.

BMC Genomics. 2007 Apr 3;8:91.

3.

A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.

Härmä V, Virtanen J, Mäkelä R, Happonen A, Mpindi JP, Knuuttila M, Kohonen P, Lötjönen J, Kallioniemi O, Nees M.

PLoS One. 2010 May 3;5(5):e10431. doi: 10.1371/journal.pone.0010431.

5.

Epithelial-to-mesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cells.

Serova M, Astorgues-Xerri L, Bieche I, Albert S, Vidaud M, Benhadji KA, Emami S, Vidaud D, Hammel P, Theou-Anton N, Gespach C, Faivre S, Raymond E.

Mol Cancer Ther. 2010 May;9(5):1308-17. doi: 10.1158/1535-7163.MCT-10-0167.

6.

Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery.

Calcagno AM, Ludwig JA, Fostel JM, Gottesman MM, Ambudkar SV.

Mol Pharm. 2006 Jan-Feb;3(1):87-93.

PMID:
16686373
7.

Gene expression profiling of systems involved in the metabolism and the disposition of xenobiotics: comparison between human intestinal biopsy samples and colon cell lines.

Bourgine J, Billaut-Laden I, Happillon M, Lo-Guidice JM, Maunoury V, Imbenotte M, Broly F.

Drug Metab Dispos. 2012 Apr;40(4):694-705. doi: 10.1124/dmd.111.042465.

8.

Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells.

Habano W, Gamo T, Terashima J, Sugai T, Otsuka K, Wakabayashi G, Ozawa S.

BMC Cancer. 2011 Feb 22;11:81. doi: 10.1186/1471-2407-11-81.

9.

Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.

Geng S, Guo Y, Wang Q, Li L, Wang J.

Arch Dermatol Res. 2013 Jan;305(1):35-47. doi: 10.1007/s00403-012-1260-2.

PMID:
22740085
10.

Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems.

Maupin KA, Sinha A, Eugster E, Miller J, Ross J, Paulino V, Keshamouni VG, Tran N, Berens M, Webb C, Haab BB.

PLoS One. 2010 Sep 27;5(9):e13002. doi: 10.1371/journal.pone.0013002.

11.

Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.

Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM, Ellis LM.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4147-53.

12.

Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells. Status of the pRb1 and pRb2 tumor suppressor gene products.

Djelloul S, Forgue-Lafitte ME, Hermelin B, Mareel M, Bruyneel E, Baldi A, Giordano A, Chastre E, Gespach C.

FEBS Lett. 1997 Apr 14;406(3):234-42.

13.

Isolation and characterization of stem-like cells from a human ovarian cancer cell line.

Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF.

Mol Cell Biochem. 2012 Apr;363(1-2):257-68. doi: 10.1007/s11010-011-1178-6.

PMID:
22160925
14.

Immortalization and neoplastic transformation of normal rat colon epithelium: an in vitro model of colonic neoplastic progression.

Pories SE, Weber TK, Simpson H, Greathead P, Steele G Jr, Summerhayes IC.

Gastroenterology. 1993 May;104(5):1346-55.

PMID:
7683294
15.

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients.

Yauch RL, Januario T, Eberhard DA, Cavet G, Zhu W, Fu L, Pham TQ, Soriano R, Stinson J, Seshagiri S, Modrusan Z, Lin CY, O'Neill V, Amler LC.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8686-98.

16.

Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines.

Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, Beaudry C, Nakada S, Anderson EM, Henrichs AN, McDonough WS, Holz D, Joy A, Lin R, Pan KH, Lih CJ, Cohen SN, Berens ME.

BMC Genomics. 2008 Jan 29;9:54. doi: 10.1186/1471-2164-9-54.

17.

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA.

J Natl Cancer Inst. 1999 Mar 3;91(5):429-33.

PMID:
10070941
18.

Characterization of human intestinal stromal cell lines: response to cytokines and interactions with epithelial cells.

Fritsch C, Orian-Rousseaul V, Lefebvre O, Simon-Assmann P, Reimund JM, Duclos B, Kedinger M.

Exp Cell Res. 1999 May 1;248(2):391-406.

PMID:
10222131
19.

Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.

Györffy B, Serra V, Jürchott K, Abdul-Ghani R, Garber M, Stein U, Petersen I, Lage H, Dietel M, Schäfer R.

Oncogene. 2005 Nov 17;24(51):7542-51.

PMID:
16044152
20.

A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis.

Joyce T, Cantarella D, Isella C, Medico E, Pintzas A.

Clin Exp Metastasis. 2009;26(6):569-87. doi: 10.1007/s10585-009-9256-9.

PMID:
19340593

Supplemental Content

Support Center